AnaptysBio
ANAB
ANAB
135 hedge funds and large institutions have $747M invested in AnaptysBio in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.13% less ownership
Funds ownership: 109.2% → 109.06% (-0.13%)
4% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 45
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
135
Holding in Top 10
2
Calls
$794K
Puts
$707K
Top Buyers
| 1 | +$68.4M | |
| 2 | +$31.7M | |
| 3 | +$12.5M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$6.42M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.3M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$21.2M | |
| 3 | -$13.6M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$11.9M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$8.43M |